SPIDIA-DNA: An External Quality Assessment for the pre-analytical phase of blood samples used for DNA-based analyses

Clinica Chimica Acta

Volumn 424, Issue , 2013, Pages 274-286

  Malentacchi, F ^a   Pazzagli, M ^a   Simi, L ^a   Orlando, C ^a   Wyrich, R ^b   Hartmann, C C ^b   Verderio, P ^c   Pizzamiglio, S ^c   Ciniselli, C M ^c   Tichopad, A ^d,e,f   Kubista, M ^e   Gelmini, S ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b QIAGEN GMBH   (Germany)

^c NATIONAL CANCER INSTITUTE   (Italy)

^d CHARLES UNIVERSITY   (Czech Republic)

^e TATAA Biocenter AB   (Sweden)

^f INSTITUTE OF BIOTECHNOLOGY   (Czech Republic)

Author keywords

Blood samples; DNA quality; External quality assessment; Pre analytical phase

Indexed keywords

RIBONUCLEASE P;

ARTICLE; BLOOD SAMPLING; CLINICAL LABORATORY; COMPUTER PROGRAM; CONTROLLED STUDY; DNA DETERMINATION; DNA FRAGMENTATION; DNA INTEGRATION; DNA PURIFICATION; EUROPE; EVIDENCE BASED PRACTICE; GENE DOSAGE; HUMAN; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PRECIPITATION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; QUALITY CONTROL; ULTRAVIOLET SPECTROPHOTOMETRY;

BLOOD SAMPLES; DNA QUALITY; EXTERNAL QUALITY ASSESSMENT; PRE-ANALYTICAL PHASE;

BIOLOGICAL MARKERS; DNA; DNA FRAGMENTATION; ELECTROPHORESIS, GEL, PULSED-FIELD; EUROPE; HUMANS; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINES AS TOPIC; QUALITY CONTROL; RIBONUCLEASE P; SOFTWARE; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 84880643379     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2013.05.012     Document Type: Article

References (25)

1. Lieber J.C. Role of external quality assurance schemes in assessing and improving quality in medical laboratories. Clin Chim Acta 2001, 20:173-177.
2. Schwartz M.K. Genetic testing and the clinical laboratory improvement amendments of 1988:present and future. Clin Chem 1999, 45:739-745.
3. Dequeker E., Cassiman J.J. Genetic testing and quality control in diagnostic laboratories. Nat Gen 2000, 25:259-260.
4. Chen B., Richards C.S., Wilson J.A., Lyon E. Quality assurance and quality improvement in US clinical molecular genetic laboratories. Curr Protoc Hum Genet 2011, 69:9.2.1-9.2.26.
5. Orlando C., Verderio P., Maatman R., et al. EQUAL-qual: a European program for external quality assessment of genomic DNA extraction and PCR amplification. Clin Chem 2007, 53:1349-1357.
6. OECD Genetic Testing: a survey of Quality Assurance and Proficiency Testing 2007, [134 pp., ISBN-978-92-64-03201].
7. Madej R.M., Cao Z., Hall L., Neuwald P.D., Williams L.O. Proficiency testing (external quality assessment) for molecular methods, approved guideline. Clin Lab Stand Inst 2005, 25:1-51. [CLSI document MM14-A], [No. 24].
8. Kalman L., Leonard J., Gerry N., et al. Quality assurance for Duchenne and Becker muscular dystrophy genetic testing:development of a genomic DNA reference material panel. J Mol Diagn 2011, 13(2):167-174.
9. Thunnissen E., Bovee J.V., Bruinsma H., et al. EGFR and KRAS quality assurance schemes in pathology: generating normative data for molecular predicitive marker analysis in targeted therapy. J Clin Pathol 2011, 64:884-892.
10. Deans Z.C., Tull J., Beighton G., Abbs S., Robinson D.O., Butler R. Molecular genetics external quality assessment pilot scheme for KRAS analysis in metastatic colorectal cancer. Gener Test Mol Biomark 2011, 15(11):777-783.
11. Pratt V.M., Caggana M., Bridges C., et al. Development of genomic reference materials for cystic fibrosis genetic testing. J Mol Diagn 2009, 11:186-193.
12. Abbate I., Zanchetta M., Gatti M., et al. Multicenter comparative study of Epstein-Barr virus DNA quantification for virological monitoring in transplanted patients. J Clin Virol 2011, 50:224-229.
13. Pisani G., Cristiano K., Marino F., et al. External quality assessment programs for detection HCV RNA, HIV RNA, and HBV DNA in plasma: improved proficiency of the participants observed over a 2-years period. Vox Sang 2010, 99:319-324.
14. Barbi M., MacKay W.G., Binda S., van Loon A.M. External quality assessment of cytomegalovirus DNA detection on dried blood spot. BMC Microbiol 2008, 8:2.
15. Moore H.M., Kelly A., Jewell S.D., et al. Biospecimen Reporting for Improved Study Quality (BRISQ). J Proteome Res 2011, 10:3429-3438.
16. Bellissimo D.B. Practice guidelines and proficiency testing for molecular assays. Transfusion 2007, 47:79S-84S.
17. Ramsden S.C., Deans Z., Robinson D.O., et al. Monitoring standards for molecular genetic testing in the United Kingdom, The Netherlands and Ireland. Genet Test 2006, 10:147-156.
18. Visvikis S., Schlenck A., Maurice M. DNA extraction and stability for epidemiological studies. Clin Chem Lab Med 1998, 36:551-555.
19. Knebelsberger T., Stoger I. DNA extraction, preservation, and amplification. Methods Mol Biol 2012, 858:311-338.
20. Ravine D., Suthers G. Quality standards and samples in genetic testing. J Clin Pathol 2012, 65:389-393.
21. Tichopad A., Bar T., Pecen L., Kitchen R.R., Kubista M., Pfaffl M.W. Quality control for quantitative PCR based on amplification compatibility test. Methods 2010, 50:308-312.
22. Pazzagli M., Malentacchi F., Simi L., et al. SPIDIA-RNA: first external quality assessment for the pre-analytical phase of blood samples used for RNA based analyses. Methods 2013, 59(1):20-31.
23. Efron E., Tibshirana R.J. An introduction to the bootstrap 1993, Chapman and Hall, London, [436 pp.].
24. Iglewicz B., Hoaglin D.C. How to detect and handle outliers 1993, ASCQ Quality Press, Milwaukee, WI, [87 pp.].
25. Establishing Molecular testing in Clinical Laboratory Environments; Approved Guideline; MM19-A, vol 31, n.21.